UROGENITAL DISEASES, MALE

Clinical trials for UROGENITAL DISEASES, MALE explained in plain language.

Never miss a new study

Get alerted when new UROGENITAL DISEASES, MALE trials appear

Sign up with your email to follow new studies for UROGENITAL DISEASES, MALE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug cocktail aims to stall Hard-to-Treat prostate cancer

Disease control Recruiting now

This study tests a new two-drug combination (gedatolisib plus darolutamide) in men with metastatic castration-resistant prostate cancer, a type that has spread and stopped responding to standard hormone therapy. The goal is to find the safest, most effective dose and see if the c…

Matched conditions: UROGENITAL DISEASES, MALE

Phase: PHASE1, PHASE2 • Sponsor: Celcuity Inc • Aim: Disease control

Last updated May 12, 2026 13:43 UTC

UROGENITAL DISEASES, MALE

Get alerted when new UROGENITAL DISEASES, MALE trials appear

New drug cocktail aims to stall Hard-to-Treat prostate cancer